Barbara Wright

FDA investigator

Appears on 6 documents from 2000 to 2025, most often at sites in Alabama. Most often cites general responsibilities of investigators (21 CFR 312.60).

6
Documents on file
2.5
Observations per 483
2000
First seen
2025
Most recent

What they cite most

From 5 observations

Activity by year

2000: 1, 2007: 1, 2008: 1, 2009: 1, 2010: 1, 2025: 1

Where

Alabama 2 · Tennessee 2 · Indiana 1

Often inspects with

Sripal R. Mada· Dana M. Daigle

Is Barbara Wright coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Inotiv, IncOct 25, 2025 · West Lafayette, Indiana
Warning letter Warning letter, Sep 29, 2010Sep 29, 2010
fda_correspondence Sarah Cannon Research InstituteJan 29, 2009 · Memphis, Tennessee
483 Howard W. Marker, M.D., Clinical InvestigatorMay 2, 2008 · Memphis, Tennessee
Warning letter Capstone Clinical Trials, Inc.Feb 28, 2007 · Homewood, Alabama
Warning letter The Asthma and Allergy InstituteAug 31, 2000 · Mobile, Alabama

About this profile

What does Barbara Wright inspect?

Barbara Wright appears on 6 documents on file covering 2 sites, most often in Alabama.

What do they cite most often?

21 CFR 312.60 (general responsibilities of investigators), followed by 21 CFR 312.62.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Barbara Wright is dated Oct 25, 2025.